Patient Assisted Intervention for Neuropathy: Comparison of Treatment in Real Life Situations
Status:
Completed
Trial end date:
2017-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this large comparative effectiveness study led by Richard J. Barohn, MD, of
the University of Kansas Medical Center, is to learn about the safety and effectiveness of
nortriptyline, duloxetine, pregabalin and mexiletine in treating cryptogenic sensory
polyneuropathy (CSPN).